IP Library Granted Patent US 9,193,972
Granted Patent B2
US 9,193,972 · App. 14/452,049 · Granted Nov 24, 2015

Combined hairpin-antisense compositions and methods for modulating expression

Inventors: John Shanklin (Shoreham, NY); Tam Huu Nguyen (Lincoln, NE)
Assignee: Brookhaven Science Associates, LLC
C12N15/113C12N15/111C12N15/8218C12N15/8247C12N2310/11C12N2310/14C12N2310/3519C12N2310/53
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,193,972
App. No.
14/452,049
Granted
Nov 24, 2015
Kind
B2
Abstract

A nucleotide construct comprising a nucleotide sequence that forms a stem and a loop, wherein the loop comprises a nucleotide sequence that modulates expression of a target, wherein the stem comprises a nucleotide sequence that modulates expression of a target, and wherein the target modulated by the nucleotide sequence in the loop and the target modulated by the nucleotide sequence in the stem may be the same or different. Vectors, methods of regulating target expression, methods of providing a cell, and methods of treating conditions comprising the nucleotide sequence are also disclosed.

Claims (74)

1. A nucleotide construct comprising:

a nucleotide sequence that forms a stem and at least two loops;

wherein at least one of the least two loops comprises a first nucleotide sequence that modulates expression of a target;

wherein the stem comprises a second nucleotide sequence that modulates expression of a target;

wherein both the first and second nucleotide sequence modulate the expression of a target via binding to a target;

wherein the first nucleotide sequence and the second nucleotide sequence are not contiguous;

wherein the first nucleotide sequence is located entirely within at least one of the least two loops; and

wherein the target modulated by the first nucleotide sequence and the target modulated by the second nucleotide sequence may be the same or different.

2. The nucleotide construct of claim 1 , wherein the second nucleotide sequence that modulates expression of a target modulates the expression of the target through an RNAi pathway.

3. The nucleotide construct of claim 1 , wherein the first nucleotide sequence that modulates expression of a target modulates the expression of the target via antisense modulation of expression.

4. The nucleotide construct of claim 1 , further comprising a gene of interest operably linked to a promoter, and wherein the loop comprising the first nucleotide sequence may or may not comprise a nucleotide sequence that modulates expression of a target.

5. The nucleotide construct of claim 4 , wherein the gene of interest operably linked to a promoter is located in the loop comprising the first nucleotide sequence.

6. The nucleotide construct of claim 1 , further comprising one or more splice sites in the loop comprising the first nucleotide sequence.

7. The nucleotide construct of claim 1 , wherein the loop comprising the first nucleotide sequence contains more than one nucleotide sequence that modulates expression of a target.

8. The nucleotide construct of claim 1 , wherein the stem contains more than one nucleotide sequence that modulates expression of a target.

9. The nucleotide construct of claim 1 , wherein the stem contains one or more nucleotide sequences that regulate expression of one or more targets and wherein the loop comprising the first nucleotide sequence contains one or more nucleotide sequences that regulate expression of one or more targets.

10. The nucleotide construct of claim 1 , wherein the nucleotide construct comprises a PNA.

11. The nucleotide construct of claim 1 , wherein the nucleotide construct comprises a synthetic base.

12. The nucleotide construct of claim 1 , wherein the nucleotide construct comprises a modified sugar.

13. The nucleotides construction of claim 1 , wherein the stem comprises a miRNA.

14. The nucleotides construction of claim 1 , wherein at least one loop comprises a miRNA.

15. A vector comprising the nucleotide construct of claim 1 operably linked to a promoter.

16. The vector of claim 15 , wherein the promoter is selected from the group consisting of viral, retroviral, mammalian, plant, bacterial, constitutive, regulatable, fungal, yeast, and insect promoters.

17. The vector of claim 16 , wherein the plant promoter is selected from the group consisting of promoters identified in Arabidopsis, sunflower, cotton, rapeseed, maize, wheat, castor, palm, tobacco, peanut, sorghum, sugarcane, and soybean.

18. The vector of claim 15 , wherein the vector is selected from the group consisting of plasmids, cosmids, retroviral vectors, agrobacterium, viral vectors, bacterial vectors, yeast vectors, eukaryotic vectors, plant vectors, and mammalian vectors.

19. The vector of claim 15 , further comprising sequences that promote the integration into a genome of the nucleotide construct of claim 1 operably linked to a promoter.

20. A method of regulating the expression of a target, the method comprising:

providing to a cell the nucleotide construct of claim 1 ; and

culturing said cell.

21. The method according to claim 20 , wherein the cell is selected from the group consisting of prokaryotic, eukaryotic, bacterial, agrobacterium, yeast, plant, mammalian, and human cells.

22. The method according to claim 21 , herein the plant cell is selected from the group consisting of promoters identified in Arabidopsis, sunflower, cotton, rapeseed, maize, wheat, castor, palm, tobacco, peanut, sorghum, sugarcane, and soybean cells.

23. The method according to claim 20 , wherein the target is a gene, oligonucleotide sequence, and/or a protein.

24. A method of regulating the expression of a target, the method comprising:

providing to a cell a vector comprising the vector of claim 15 ; and

expressing the nucleotide construct of claim 1 from said vector in said cell.

25. The method according to claim 24 , wherein the target is a gene, oligonucleotide sequence, and/or a protein.

26. The method according to claim 24 , wherein the cell is selected from the group consisting of prokaryotic, eukaryotic, bacterial, agrobacterium, yeast, plant, mammalian, and human cells.

27. The method according to claim 26 , wherein the plant cell is selected from the group consisting of Arabidopsis, sunflower, cotton, rapeseed, maize, wheat, castor, palm, tobacco, peanut, sorghum, sugarcane, and soybean cells.

28. A cell comprising the nucleotide construct of claim 1 .

29. The cell according to claim 28 , wherein the cell is selected from the group consisting of prokaryotic, eukaryotic, bacterial, agrobacterium, yeast, plant, mammalian, and human cells.

30. The cell according to claim 29 wherein the plant is selected from the group consisting of Arabidopsis, sunflower, cotton, rapeseed, maize, wheat, castor, palm, tobacco, peanut, sorghum, sugarcane, and soybean.

31. The nucleotide construct according to claim 1 , wherein the target modulated by the first nucleotide sequence, the target modulated by the second nucleotide sequence, or both are a nucleic acids involved in fatty acid synthesis.

32. The nucleotide construct according to claim 1 , wherein the construct is present in a cell comprising the target modulated by the first nucleotide sequence and the target modulated by the second nucleotide sequence.

33. A nucleotide construct comprising:

a nucleotide sequence that forms a stem and at least two loops;

wherein at least one of the at least two loops comprises a first nucleotide sequence that modulates expression of a target;

wherein the stem comprises a second nucleotide sequence that modulates expression of a target;

wherein both the first and second nucleotide sequence modulate the expression of a target via binding to a target;

wherein the target modulated by the first nucleotide sequence and the target modulated by the second nucleotide sequence may be the same or different;

wherein the first nucleotide sequence is located entirely within the loop comprising the first nucleotide sequence; and

wherein the first nucleotide sequence and the second nucleotide sequence each comprise an antisense sequences capable of modulating the expression of a gene selected from the group consisting of FAB1, FAD2, and FAD3.

34. The nucleotides construction of claim 33 , wherein the stem comprises a miRNA.

35. The nucleotides construction of claim 33 , wherein at least one loop comprises a miRNA.

36. A nucleotide construct comprising:

a nucleotide sequence that forms a stem and at least two loops;

wherein at least one of the at least two loops comprises a first nucleotide sequence of at least ten contiguous bases that are complementary to a target;

wherein the stem comprises a second nucleotide sequence of at least ten contiguous bases that are complementary to a target;

wherein both the first and second nucleotide sequence are able to hybridize with a target;

wherein the first nucleotide sequence and the second nucleotide sequence are not contiguous;

wherein the first nucleotide sequence is located entirely within the loop comprising the first nucleotide sequence; and

wherein the target of the first nucleotide sequence and the target of the second nucleotide sequence may be the same or different.

37. The nucleotides construction of claim 36 , wherein the stem comprises a miRNA.

38. The nucleotides construction of claim 36 , wherein at least one loop comprises a miRNA.

39. A nucleotide construct comprising:

a nucleotide sequence that forms a stem and at least two loops;

wherein at least one of the at least two loops comprises a first nucleotide sequence that modulates expression of a target;

wherein the stem comprises a second nucleotide sequence that modulates expression of a target;

wherein both the first and second nucleotide sequence modulate the expression of a target via binding to a target;

wherein the first nucleotide sequence and the second nucleotide sequence are not contiguous;

wherein the first nucleotide sequence is located entirely within the loop comprising the first nucleotide sequence;

wherein the nucleotide construct comprises splice sites configured so as to allow at least a portion of the loop comprising the first nucleotide sequence to be spliced away from the stem; and

wherein the target modulated by the first nucleotide sequence and the target modulated by the second nucleotide sequence may be the same or different.

40. The nucleotides construction of claim 39 , wherein the stem comprises a miRNA.

41. The nucleotides construction of claim 40 , wherein at least one loop comprises a miRNA.

Assignments (3)
CONFIRMATORY LICENSE Recorded Apr 28, 2022
From: BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 059765/0721 →
CONFIRMATORY LICENSE Recorded May 17, 2017
From: BROOKHAVEN SCIENCE ASSOCIATES, LLC
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 042522/0274 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2015
From: SHANKLIN, JOHN; NGUYEN, TAM HUU
To: BROOKHAVEN SCIENCE ASSOCIATES, LLC
Reel/Frame 036220/0525 →
Continuity (3)
Continuation 12052658 · Mar 20, 2008
Provisional Application 60896212 · Mar 21, 2007
Related Publication 20140342453A1 · Nov 20, 2014